Internal Medicine, Hematology & Oncology · Fort Worth, TX
NPI
1457453599
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
500 S Henderson St Ste 200
Fort Worth, TX, 76104
Phone (174) 131-5008
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
90,988 services
Medicare patients, 2024
680
Average age 75
Drug cost, 2024
$5.4M
2,401 prescriptions
Company payments, 2025
$1,295
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjay P Oommen was code J1453 (injection, fosaprepitant, 1 mg), 9,600 times for 39 patients. In total Sanjay P Oommen billed 90,988 services in 169 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 9,600 | 39 | $0.11 | $1,076 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,730 | 25 | $44.51 | $389K |
| J9267 Injection, paclitaxel, 1 mg | Office | 8,186 | 23 | $0.08 | $654 |
| J9025 Injection, azacitidine, 1 mg | Office | 8,100 | 15 | $0.29 | $2,388 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 5,000 | 15 | $2.35 | $12K |
| J0897 Injection, denosumab, 1 mg | Office | 1,680 | 12 | $20.59 | $35K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,400 | 76 | $0.09 | $125 |
| 36415 Venipuncture Blood Collection | Office | 1,053 | 367 | $8.65 | $9,108 |
| 85025 Blood Count | Office | 990 | 365 | $7.59 | $7,513 |
| 80053 Clinical Chemistry | Office | 979 | 373 | $10.33 | $10K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 840 | 48 | $0.75 | $629 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 720 | 41 | $0.25 | $181 |
| 99214 Office E&M - Established | Office | 601 | 284 | $92.13 | $55K |
| J9045 Injection, carboplatin, 50 mg | Office | 306 | 28 | $2.86 | $875 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 295 | 35 | $70.09 | $21K |
By year: 2022 $1.2M for 51,663 services; 2023 $1.5M for 72,853 services; 2024 $1.6M for 90,988 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,053 | 367 | $8.65 | $9,108 |
| 85025 Blood Count | 990 | 365 | $7.59 | $7,513 |
| 80053 Clinical Chemistry | 979 | 373 | $10.33 | $10K |
| 82784 Immunoassay | 235 | 40 | $9.01 | $2,117 |
| 83521 Immunoassay | 170 | 46 | $16.74 | $2,846 |
| 83540 Clinical Chemistry | 162 | 96 | $6.34 | $1,027 |
| 83550 Clinical Chemistry | 162 | 96 | $8.57 | $1,388 |
| 82728 Clinical Chemistry | 144 | 86 | $13.36 | $1,924 |
| 82378 Clinical Chemistry | 73 | 26 | $18.58 | $1,356 |
| 84443 Clinical Chemistry | 67 | 34 | $16.46 | $1,103 |
Medicare prescription drug claims, 2024
In 2024, the drug Sanjay P Oommen prescribed most often to Medicare patients was Anastrozole, with 207 prescriptions and refills. In total Sanjay P Oommen wrote 2,401 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 207 | 505 | 68 | $3,364 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 199 | 199 | 50 | $9,905 |
| Eliquis Apixaban | 139 | 183 | 34 | $104K |
| Gabapentin Generic | 81 | 155 | 23 | $1,436 |
| Xarelto Rivaroxaban | 79 | 156 | 21 | $84K |
| Dexamethasone Generic | 76 | 82 | 38 | $1,288 |
| Morphine Sulfate Er Morphine Sulfate | 69 | 69 | 18 | $2,513 |
| Acyclovir Generic | 65 | 90 | 17 | $454 |
| Hydroxyurea Generic | 63 | 146 | 15 | $1,375 |
| Levothyroxine Sodium Generic | 61 | 121 | 16 | $461 |
| Olanzapine Generic | 57 | 57 | 35 | $220 |
| Prednisone Generic | 50 | 62 | 17 | $206 |
| Ibrance Palbociclib | 47 | 51 | Under 11 | $801K |
| Revlimid Lenalidomide | 47 | 47 | Under 11 | $840K |
| Tramadol Hcl Generic | 46 | 46 | 24 | $743 |
Brand drugs: 548 claims; generic drugs: 1,853 claims; opioid claims: 426.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjay P Oommen $1,295 ($1,295 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,023.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.